Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • fungs
    Member
    • Jan 2010
    • 10

    Primer design reference positions

    Hello,
    this might seem like a very basic question but I could not find a clear answer, yet. So I am hoping that anyone here is familiar with this matter.

    I'm dealing with 16S primers for hypervariable regions. There are some primer variants like '967F' that are published in literature and used to amplify these regions. I know that positions are usually given in terms of E.coli genome positions. This would mean that the Primer 5' start position is at the 967th base of the corresponding reference E.coli 16S rRNA gene? Then, I would like to know which E.coli genome and which rRNA copy in the genome is specifically taken as reference. There are so many E.coli sequences in public databases...

    Yes, I could probably align the primers to any of the reference sequences but I would like to know the definition.

    Thanks for your help, if you happen to know.

    J.
  • nmcnulty
    Junior Member
    • Feb 2013
    • 1

    #2
    Primer design reference positions

    I found your post while searching around for an answer to the same question. After a fair bit of digging, I found some articles suggesting that the E. coli 16S numbering scheme is based on the sequence reported by Brosius et al. in PNAS in 1978:



    For completeness, here is one of the articles claiming this is the scheme used:

    Comment

    • fungs
      Member
      • Jan 2010
      • 10

      #3
      Thx

      Never thanked you for your answer. Thx!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM
      • GATTACAT
        Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by GATTACAT
        Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
        07-01-2026, 11:43 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:26 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Working...